Back to Authors

Master, Zubin

https://orcid.org/0000-0002-3462-4546

Mayo Clinic

Wake Forest University Health Sciences

Citations 28

Health Misinformation and the Power of Narrative Messaging in the Public Sphere
Murdoch, Blake , Brown, Jasmine M., Perrault, Sarah Tinker, Jarry, Jonathan, Anthony, Samantha J. , Ogbogu, Ubaka , Greenberg, Joshua , Zarzeczny, Amy , Hyde-Lay, Robyn, Caulfield, Timothy , Marcon, Alessandro R , Snyder, Jeremy , Brooks, Stephanie P. , Master, Zubin , Rachul, Christen M.

Canadian Journal of Bioethics | June 18, 2019 | Volume: 2 | Issue: 2 | Pages: 52-60

10.7202/1060911ar Get It

Numerous social, economic and academic pressures can have a negative impact on representations of biomedical research. We review several of the forces playing an increasingly pernicious role in how health and science information is interpreted, shared and used, drawing discussions towards the role of narrative. In turn, we explore how aspects of narrative are used in different social contexts and communication environments, and present creative responses that may help counter the negative trends. As traditional methods of communication have in many ways failed the public, changes in approach are required, including the creative use of narratives.
Fostering a prevention mindset for responsible gene editing
Meagher, Karen M. , Master, Zubin , Master, Zubin , Meagher, Karen M

Accountability in Research | May 10, 2019 | Volume: 26 | Issue: 4 | Pages: 251-256

10.1080/08989621.2019.1617140 Get It

Preparing Regenerative Therapies for Clinical Application: Proposals for Responsible Translation
Smith, Cambray , Arthurs, Jennifer R. , Master, Zubin , Smith, Cambray G, Master, Zubin , Shapiro, Shane A.

Regenerative Medicine | January 17, 2019 | Volume: 14 | Issue: 2 | Pages: 77-84

10.2217/rme-2018-0163 Get It

Procedures to Promote Ethical Open Access Publishing: A Comment to Shaw and Elger
Master, Zubin

Accountability in Research | November 13, 2018 | Volume: 25 | Issue: 7-8 | Pages: 417-418

10.1080/08989621.2018.1547966 Get It

The stem cell market and policy options: a call for clarity
Zarzeczny, Amy , Illes, Judy , Master, Zubin , Robillard, Julie M. , Turner, Leigh , Zettler, Patricia J. , Master, Zubin , Atkins, Harold L. , Kimmelman, Jonathan , Snyder, Jeremy , Caulfield, Timothy

Journal of Law and the Biosciences | October 15, 2018 | Volume: 5 | Issue: 3 | Pages: 743-758

10.1093/jlb/lsy025 Get It

Weaponizing Hope: Sources of Hope, Unrealistic Optimism, and Denial
Michie, Marsha , Allyse, Megan , Stoll, Katie , Allyse, Megan A , Master, Zubin

The American Journal of Bioethics | September 20, 2018 | Volume: 18 | Issue: 9 | Pages: 25-27

10.1080/15265161.2018.1498946 Get It

Expanding the Scope of Research Ethics Consultation Services in Safeguarding Research Integrity: Moving Beyond the Ethics of Human Subjects Research
Martinson, Brian C. , Resnik, David B. , Martinson, Brian C , Master, Zubin

The American Journal of Bioethics | January 9, 2018 | Volume: 18 | Issue: 1 | Pages: 55-57

10.1080/15265161.2017.1401167 Get It

Industry Responsibilities in Tackling Direct‐to‐Consumer Marketing of Unproven Stem Cell Treatments
Master, Zubin , Fu, Wayne , Paciulli, Danielle, Sipp, Douglas , Master, Zubin

Clinical Pharmacology & Therapeutics | July 11, 2017 | Volume: 102 | Issue: 2 | Pages: 177-179

10.1002/cpt.704 Get It

The direct‐to‐consumer marketing of unproven stem cell interventions (SCIs) is a serious public health concern. Regulations and education have had modest impact, indicating that different actors must play a role to stop this unfettered market. We consider the role of the biotech industry in tackling unproven SCIs. Grounded in the concept of corporate social responsibility, we argue that biotech companies should screen consumers to ensure that products and services are being used appropriately and educate employees about unproven SCIs.